- Report
- June 2025
- 250 Pages
India
From €2448EUR$2,789USD£2,118GBP
- Report
- June 2025
- 250 Pages
Mexico
From €2448EUR$2,789USD£2,118GBP
- Report
- June 2025
- 250 Pages
South Korea
From €2448EUR$2,789USD£2,118GBP
- Report
- June 2025
- 250 Pages
Brazil
From €2448EUR$2,789USD£2,118GBP
- Report
- June 2025
- 250 Pages
Australia
From €2448EUR$2,789USD£2,118GBP
- Report
- September 2023
- 119 Pages
Global
From €3949EUR$4,500USD£3,417GBP
- Report
- October 2022
- 113 Pages
Global
From €3467EUR$3,950USD£2,999GBP
- Report
- January 2022
- 110 Pages
Global
From €3200EUR$3,906USD£2,866GBP
The 3D Bioprinter market is a subset of the biotechnology industry that focuses on the development and production of 3D bioprinters. These devices are used to create 3D structures from biological materials such as cells, proteins, and other biomaterials. The 3D bioprinting process is used to create tissue-like structures for medical research, drug testing, and tissue engineering. It is also used to create personalized medical implants and prosthetics.
The 3D bioprinting market is expected to grow rapidly in the coming years due to increasing demand for personalized medical implants and prosthetics, as well as the development of new technologies and materials. Additionally, the increasing use of 3D bioprinters in drug discovery and development is expected to drive the market growth.
Some of the major companies in the 3D bioprinting market include Stratasys, 3D Systems, Organovo, EnvisionTEC, Aspect Biosystems, BioBots, and Cyfuse Biomedical. Show Less Read more